Eli Lilly’s lead in the obesity race gets wider after win against Novo
In the lucrative obesity drug race, there is Eli Lilly — and then there’s everybody else. A pair…
Updates for July 21-25, 2025
It all comes back to tech, once again. Magnificent Seven earnings kick off in the week ahead, with…